Clinical Trials Directory

Trials / Unknown

UnknownNCT05758272

Evaluation of a Workplace Smoking Cessation Program in Hong Kong (Phase VI)

Evaluation of a Workplace Smoking Cessation Program in Hong Kong: a Pragmatic Cluster Randomized Controlled Trial of Mobile Supported Simple Physical Exercise for Smoking Cessation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
646 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This study aims to test, by a 2-arm RCT, the effectiveness of an intervention that includes mobile phone-supported simple physical exercise for smoking cessation in workplaces in Hong Kong.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmobile phone-based simple physical exercise reminder to help quit smokingRegular messages supporting participants in practicing simple physical exercises and assist in managing cravings will be sent to participants via IM apps and scheduled in a tapering manner for 3 months (twice per week in the first month to once per week in the third month). Images and videos explaining and demonstrating the simple physical exercises will be sent to the participants via IM apps, which serves as a reminder and supporting materials for participants. The benefits of exercise in SC will be explained. The investigator will also encourage the practice of moderate/ vigorous exercises to further improve the physical activity and well-being of the participants. Various delivery formats of messages will be considered to attract participants' interest such as text, emojis, voice, image, animation, and video. The simple exercises consist of a) Zero-time exercises (ZTEx), b) handgrip exercises and c) resistance exercises.
BEHAVIORALregular text-based interventionThe control group will receive 6 regular messages via IM at twice per month within 3 months. These messages cover simple cessation advice and reminders for telephone follow-ups.

Timeline

Start date
2023-01-01
Primary completion
2024-06-30
Completion
2024-12-30
First posted
2023-03-07
Last updated
2023-12-13

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05758272. Inclusion in this directory is not an endorsement.